Sutton's disease is characterized by giant necrotizing ulcers around minor salivary glands and is of unknown cause. We report a case, review the medical literature, and discuss the treatment of this affliction.
VincentSDLillyGE. Clinical history and therapeutic features of aphthous stomatitis. Literature review and open clinical trial employing steroids. Oral Surg Oral Med Oral Pathol1992; 74: 79–86.
4.
PedersenAKlausenBHougenHPRyderLWintherK. Immunomodulation by LongoVital in patients with recurrent aphthous ulceration. J Oral Pathol Med1990; 19: 376–80.
5.
SavageNWMahanondaRSeymourGJBrysonGJCollinsRJ. The proportion of suppressor-inducer T-lymphocytes is reduced in recurrent aphthous stomatitis. J Oral Pathol1988; 17: 293–7.
6.
DeFriesHO. Stomatitis. In: GatesGA, ed. Current therapy in otolaryngology–head and neck surgery. Toronto, Canada: BC Decker, 1987: 307–10.
7.
CohenL. Etiology, pathogeny and classification of aphthous stomatitis and Behcet's syndrome. J Oral Pathol1978; 7: 347–52.
8.
KowolikMJMuirKFMacpheeIT. Di-sodium cromoglycate in the treatment of recurrent aphthous ulceration. Br Dent J1978; 144: 384–6.
MerchantHWGangarosaLPGlassmanABSobelRE. Betamethasone-17-benzoate in the treatment of recurrent aphthous ulcers. Oral Surg Oral Med Oral Pathol1978; 45: 870–5.
21.
PinquierLRevuzJ. Traitement de l'aphthose bucale récidivante. Ann Dermatol Venereol1987; 114: 751–7.
22.
DenmanAMSchiffAA. Recurrent oral ulceration. Treatment with Mysteclin: A controlled study. Br Med J1979; 1: 1248–9.
23.
MillerMFChiltonNW. The effect of an oxygenating agent upon recurrent aphthous stomatitis. Pharmacol Ther Dent1980; 5: 55–6.
24.
WrayD. A double-blind trial of systemic zinc sulfate in recurrent aphthous stomatitis. Oral Surg Oral Med Oral Pathol1982; 53: 469–72.
WormserGPMackLLenoxT. Lack of effect of oral acyclovir on prevention of aphthous stomatitis. Otolaryngol Head Neck Surg1988; 98: 14–7.
30.
BrownRSBottomleyWK. Combination immunosuppressant and topical steroid therapy for treatment of recurrent major aphthae. Oral Surg Oral Med Oral Pathol1990; 69: 42–4.
31.
EhrenfeldMLevyMBar EliMGallilyREliakimM. Effect of colchicine on polymorphonuclear leucocyte chemotaxis in human volunteers. Br J Clin Pharmacol1980; 10: 297–300.
32.
DjianBSantoniAGuilhouJMeynadierJ. Traitement de l'aphthose vulgaire récidivante par la colchicine. Nouv Presse Med1982; 11: 3799.
33.
LehnerTWiltonJMAIvanyiL. Double blind crossover trial of levamisole in recurrent aphthous ulceration. Lancet1976; 11: 926–9.
34.
GierREGeorgeBWilsonT. Evaluation of the therapeutic effect of levamisole in treatment of recurrent aphthous stomatitis. J Oral Pathol1978; 7: 405–13.
35.
KaplanBCardarelliCPinnelSR. Double blind study of levamisole therapy in recurrent aphthous stomatitis. J Oral Pathol1978; 7: 393–9.
36.
De MeyerJDegraeveMClarysseJDe LooseFPeremansW. Levamisole in aphthous stomatitis: Evaluation of three regimens. Br Med J1977; 1: 671–4.
37.
MillerMFSilvertMELasterLLGreenPShipII. Effect of levamisole on the incidence and prevalence of recurrent aphthous stomatitis. A double blind trial. J OralPathol1978; 7: 387–92.
38.
OlsonJASilvermanSRJr.. Double blind study of levamisole therapy in recurrent aphthous stomatitis. J Oral Pathol1978; 7: 393–9.
39.
SheskinJ. The treatment of lepra reaction in lepromatous leprosy. Fifteen years experience with thalidomide. Int J Dermatol1980; 19: 318–22.
40.
JorrizoJLSchmalstiegFCSalomonAR. Thalidomide effects in Behcet's syndrome and pustular vasculitis. Arch Intern Med1986; 146: 878–81.
41.
BarnhillRLMcDougallAC. Thalidomide use and possible mode of action in reactional lepromatous leprosy and in various other conditions. J Am Acad Dermatol1982; 7: 317–23.
42.
FaureMThivoletJGaucherandM. Inhibition of PMM leucocytes chemotaxis by thalidomide. Arch Dermatol Res1980; 269: 275–80.
43.
RevuzJGuillaumeJCJanierM. Crossover study of thalidomide versus placebo in severe recurrent aphthous stomatitis. Arch Dermatol1990; 126: 923–7.
44.
JenkinsJSPowellRJAllenBRLittlewoodSMMauricePDLSmithNJ. Thalidomide in severe orogenital ulceration. Lancet1984; II: 1424–5.
45.
KürçüogluNAtakanNEksiogluM. Thalidomide in the treatment of recurrent necrotic mucocutaneous aphthae. Br J Dermatol1985; 112: 632.
46.
BrothagenH. Significant response of oral aphthosis to thalidomide treatment. J Am Acad Dermatol1985; 13: 509.
47.
MellinGWKatzensteinM. The saga of thalidomide: Neuropathy to embryopathy with case reports of congenital anomalies. N Engl J Med1962; 267: 1184–244.
48.
PorterSRScullyC. Aphthous stomatitis — An overview of aetiopathogenesis and management. Clin Exp Dermatol1991; 16: 235–43.
